Research Programme Sample Clauses
The 'RESEARCH PROGRAMME' clause defines the scope, objectives, and structure of the research activities to be undertaken under an agreement. It typically outlines the specific tasks, milestones, deliverables, and timelines that the parties have agreed upon, and may also specify roles and responsibilities for each participant. By clearly setting out the framework for the research collaboration, this clause ensures that all parties have a shared understanding of what is expected, thereby minimizing misunderstandings and facilitating effective project management.
Research Programme. EVOTEC and BOEHRINGER wish to enter into a joint research collaboration in order to identify small chemical entity therapeutics which act as GPCR modulators. Their first and initial priority is GPCR targets **** but the collaboration may include additional GPCR target opportunities for other diseases, including but not limited to ****, ****, ****, **** and **** areas. The Parties acknowledge that EVOTEC OAI AG has entered into an exclusive collaboration in the area of ****. The GPCR Targets in the respective indication area will be determined by the appropriate committee in accordance with the provisions of Section 3. The Research Programme is also intended to generate proprietary know how with respect to GPCRs to be incorporated into ****. Targets shall be selected within the following classes: **** **** **** The Research Plan will be set up in accordance with Section 3. * Portions of this document marked with **** have been omitted pursuant to a request for confidential treatment submitted with the SEC.
Research Programme. The scientific programme builds the foundation of a long-term European research & training network in the field of optimal control theory, with emphasis
Research Programme. 2.1 Following signature of this AGREEMENT and payment to ARROW by TRIANGLE of the sum set out in Section 6.1 hereof,
2.1.1 ARROW shall initiate the screening campaign as set out in the RESEARCH PROGRAMME. ARROW shall use its best efforts to identify one or more lead candidates for evaluation by TRIANGLE but the final selection and prioritisation of SELECTED COMPOUNDS to be screened in the HCV Replicase Assay will be made by the JOINT STEERING COMMITTEE. For purposes of this AGREEMENT, "best efforts" shall mean that ARROW shall use efforts which are consistent with those used by it in its other research projects deemed to have comparable commercial potential.
2.1.2 ARROW and TRIANGLE shall set up a JOINT STEERING COMMITTEE with representatives from both companies, the function and terms of reference of which are set out in Article 8 hereof.
2.1.3 ARROW and TRIANGLE shall collaborate through the auspices of the JOINT STEERING COMMITTEE to agree protocols for the pre-clinical (ADME studies) and the clinical studies in good time prior to their intended commencement dates.
2.2 For the duration of the RESEARCH PROGRAMME as defined in Section 2.3 hereof, TRIANGLE shall have the right to submit up to *** compounds to be screened by ARROW at *** cost to TRIANGLE and the prioritisation of the TRIANGLE-SOURCED COMPOUNDS to be screened in the HCV Replicase Assay will ---------- *** Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. be made by the JOINT STEERING COMMITTEE.
2.3 The RESEARCH PROGRAMME shall continue for an *** from EFFECTIVE DATE hereof extendable for up to a *** at TRIANGLE'S request subject to agreement by both parties of the terms of such extension including the costs therefor.
2.4 A SELECTED COMPOUND, will be removed by ARROW from the library of ARROW-SOURCED COMPOUNDS for all further screening purposes immediately following selection thereof. ARROW agrees not to use the library of ARROW-SOURCED COMPOUNDS in any screening programme for any HCV activity for the duration of the RESEARCH PROGRAMME.
2.5 Upon TRIANGLE's request, ARROW will promptly provide TRIANGLE with such information in ARROW's possession as may be reasonably useful to assist the JOINT STEERING COMMITTEE in its efforts to make a selection from the ARROW-SOURCED COMPOUNDS.
Research Programme. The research programme agreed between the contracting parties consists of a series of activities described in the attached technical outline, which also reports the objectives to be pursued. Updates to the detailed activity plan may be agreed by the contract’s scientific supervisors in relation to the progress of the activities, within the limits of the research programme in question.
Research Programme. 2.01 CAT and HGS will conduct collaborative research and development with respect to Target 1 and to each subsequent Target designated pursuant to Clause 20 ("the Research Programme").
2.02 Each Party will mutually disclose all information concerning Target Antibodies and the Target, which is necessary for each to perform their duties under the Research Programme, including information relating to selection, derivation and assays relating to Target Antibodies and the Target as developed under the Research Programme. HGS shall specify the animal model for demonstration of In-Vivo Proof of Concept in respect of Target 1 not later than [***] after the Effective Date. HGS shall specify the animal model for demonstration of In-Vivo Proof of Concept in respect of Targets 2 and 3 by a date to be agreed by the JMC.
2.03 The Parties will establish a Joint Management Committee ("JMC") pursuant to Article 4 and each Party shall fund its own costs of the Research Programme. The Parties will collaborate and if required by the JMC employees will work with employees of the other Party at that Party's premises.
2.04 The purpose of the Research Programme will be to generate diverse panels of Target Antibodies and to use them to explore in vivo and in vitro biological characteristics and disease association of the Target and to generate a lead Target Antibody for pre-clinical and subsequent development of a Clinical Development Antibody.
2.05 The parties shall use reasonable efforts to fulfill their obligations as set out in Exhibit A to develop a Clinical Development Antibody and in respect of Targets 2 and 3 to meet any applicable Technical Performance Criteria in respect of Targets 2 and 3.
Research Programme. The IT4BI-DC research programme has been established to tackle six fundamental BI challenges for the years to come: Modeling and Semantics, Information Discovery, Information Integration, Big Data Analytics, Large-Scale Processing, and Collaboration and Privacy. A set of Joint Doctoral Topics will be offered from a European-wide coordinated list, each topic fitting within at least one of the six BI challenges. The topics will be competitively selected for their high scientific quality and for their appropriateness with the jointly designed research agenda. Each topic is jointly co-supervised by two universities of the Consortium. The associated partners will provide input for topic definition.
Research Programme